Global Health Clinics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jay Dhaliwal
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.3yrs |
| CEO ownership | n/a |
| Management average tenure | 5.3yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Apr 30 2024 | n/a | n/a | -CA$1m |
| Jan 31 2024 | n/a | n/a | -CA$1m |
| Oct 31 2023 | n/a | n/a | -CA$1m |
| Jul 31 2023 | n/a | n/a | -CA$2m |
| Apr 30 2023 | n/a | n/a | -CA$2m |
| Jan 31 2023 | n/a | n/a | -CA$1m |
| Oct 31 2022 | n/a | n/a | -CA$2m |
| Jul 31 2022 | CA$180k | CA$180k | -CA$1m |
| Apr 30 2022 | n/a | n/a | -CA$8m |
| Jan 31 2022 | n/a | n/a | -CA$8m |
| Oct 31 2021 | n/a | n/a | -CA$9m |
| Jul 31 2021 | CA$180k | CA$180k | -CA$8m |
| Apr 30 2021 | n/a | n/a | -CA$2m |
| Jan 31 2021 | n/a | n/a | -CA$2m |
| Oct 31 2020 | n/a | n/a | -CA$2m |
| Jul 31 2020 | CA$135k | CA$135k | -CA$2m |
| Apr 30 2020 | n/a | n/a | -CA$15m |
| Jan 31 2020 | n/a | n/a | -CA$15m |
| Oct 31 2019 | n/a | n/a | -CA$15m |
| Jul 31 2019 | CA$5k | CA$5k | -CA$16m |
Compensation vs Market: Insufficient data to establish whether Jay's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Jay's compensation has been consistent with company performance over the past year.
CEO
Jay Dhaliwal (35 yo)
5.3yrs
Tenure
CA$180,000
Compensation
Mr. Jatinder Dhaliwal, also known as Jay, serves as a Director of NAVCO Pharmaceuticals Inc since January 18, 2024. He is Independent Director of LQR House Inc. from August 21, 2023. He has served as inter...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.3yrs | CA$180.00k | no data | |
| CFO & Director | 4.5yrs | CA$36.00k | no data | |
| Corporate Secretary | 5.9yrs | no data | no data |
5.3yrs
Average Tenure
Experienced Management: LRSN.F's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 5.3yrs | CA$180.00k | no data | |
| CFO & Director | 4.5yrs | CA$36.00k | no data | |
| Independent Director | 5.2yrs | CA$5.00k | no data | |
| Director | less than a year | no data | no data |
4.8yrs
Average Tenure
Experienced Board: LRSN.F's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/26 09:17 |
| End of Day Share Price | 2024/04/29 00:00 |
| Earnings | 2024/04/30 |
| Annual Earnings | 2023/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Global Health Clinics Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|